In situ non-canonical activation and sensitization of cGAS-STING pathway with manganese telluride nanosheets.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39933314.
- Also identified by DOI 10.1016/j.biomaterials.2025.123170.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Immune checkpoint blockade (ICB) has achieved encouraging outcome in various malignant tumors. However, the low immunogenicity and insufficient infiltration of T cells within tumors severely limit the curative effects. Herein, we reported synthesis and experimental evaluation of H<sub>2</sub>O<sub>2</sub>-responsive MnTe<sub>2</sub> nanosheets (NSs) for improving anti-tumor immune responses. Within the tumor microenvironment characterized by high level of H<sub>2</sub>O<sub>2</sub>, the MnTe<sub>2</sub> NSs were degraded to release Mn<sup>2+</sup> and TeO<sub>4</sub><sup>2-</sup> which subsequently induced cellular endoplasmic reticulum (ER) stress and non-canonically activated the cGAS-STING pathway. Moreover, the cellular Mn<sup>2+</sup> ions enhanced the sensitivity of cGAS-STING pathway and the maturation of dendritic cells (DCs) concurrently. Ultimately, the MnTe<sub>2</sub> NSs exhibited favorable in vivo anti-tumor immune effects, especially in combination with PD-L1 checkpoint inhibitors. These findings provided compelling evidence for exploration and utilization of nanomedicine to leverage innate immune system for better tumor immunotherapy.
Medical subject headings
- Nucleotidyltransferases
- Tellurium
- Membrane Proteins
- Manganese
- Nanostructures